EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PW Medtech Group's enterprise value is HK$-169.1 Mil.
PW Medtech Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil. Therefore, PW Medtech Group's EV-to-EBITDA for today is -0.67.
The historical rank and industry rank for PW Medtech Group's EV-to-EBITDA or its related term are showing as below:
HKSE:01358'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.13 Med: 12.19 Max: 36.57
Current: -0.35
During the past 12 years, the highest EV-to-EBITDA of PW Medtech Group was 36.57. The lowest was -2.13. And the median was 12.19.
HKSE:01358's EV-to-EBITDA is ranked better than 99.17% of 483
companies
in the Medical Devices & Instruments industry
Industry Median: 16.09
vs HKSE:01358: -0.35
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
PW Medtech Group EV-to-EBITDA Historical Data
The historical data trend for PW Medtech Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PW Medtech Group's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, PW Medtech Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PW Medtech Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PW Medtech Group's EV-to-EBITDA falls into.
PW Medtech Group's current Enterprise Value is HK$-169.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$252.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PW Medtech Group (HKSE:01358) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PW Medtech Group's PE Ratio for today is calculated as:
PW Medtech Group's share price for today is HK$1.09.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PW Medtech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.107.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of PW Medtech Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
PW Medtech Group (HKSE:01358) Business Description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01358 has been successfully added to your 